Sera Prognostics (SERA) Gains from Sales and Divestitures (2024 - 2026)
Sera Prognostics (SERA) reported Gains from Sales and Divestitures of $187309.0 for Q1 2026, down 41.13% on a YoY basis from $318154.0 in Q1 2025, and down 85.12% quarter-over-quarter from $1.3 million in Q4 2025.
Sera Prognostics (SERA) Gains from Sales and Divestitures (2024 - 2026) Analysis & Trends
Sera Prognostics has reported Gains from Sales and Divestitures for 3 years, with the latest figure at $187309.0 in Q1 2026.
- For the quarter ending Q1 2026, Gains from Sales and Divestitures fell 41.13% year-over-year to $187309.0; the trailing twelve-month figure through Mar 2026 stood at $187309.0 (down 41.13% YoY), and the FY2025 full-year result was $1.3 million, changed 0.14% from the prior year.
- Gains from Sales and Divestitures for Q1 2026 stood at $187309.0, down from $1.3 million in the prior quarter.
- The five-year high for Gains from Sales and Divestitures was $1.3 million in Q4 2025, with the low at $187309.0 in Q1 2026.
- Historically, Gains from Sales and Divestitures has averaged $797153.7 across 3 years, with a median of $944114.0 in 2025.
- Annual changes were most pronounced in 2025 — Gains from Sales and Divestitures grew 0.14% — and 2026, when it sank 41.13%.
- Sera Prognostics' Gains from Sales and Divestitures stood at $1.3 million in 2024, then rose by 0.14% to $1.3 million in 2025, then slumped by 85.12% to $187309.0 in 2026.
- The last three Gains from Sales and Divestitures figures came in at $187309.0 (Q1 2026), $1.3 million (Q4 2025), and $944114.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn |
| 10 | Sera Prognostics | 93.48 Mn | 93.48 Mn | -28,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 187,309.00 |
| Mar 31, 2026 | 187,309.00 |
| Dec 31, 2025 | 1.26 Mn |
| Dec 31, 2025 | 1.26 Mn |
| Sep 30, 2025 | 944,114.00 |
| Sep 30, 2025 | 944,114.00 |
| Jun 30, 2025 | 623,374.00 |
| Jun 30, 2025 | 623,374.00 |
| Mar 31, 2025 | 318,154.00 |
| Mar 31, 2025 | 318,154.00 |
| Dec 31, 2024 | 1.26 Mn |
| Dec 31, 2024 | 1.26 Mn |
| Sep 30, 2024 | 990,613.00 |
| Sep 30, 2024 | 990,613.00 |